<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">actabiomedica</journal-id><journal-title-group><journal-title xml:lang="ru">Acta Biomedica Scientifica</journal-title><trans-title-group xml:lang="en"><trans-title>Acta Biomedica Scientifica</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2541-9420</issn><issn pub-type="epub">2587-9596</issn><publisher><publisher-name>Scientific Centre for Family Health and Human Reproduction Problems</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.29413/ABS.2023-8.3.17</article-id><article-id custom-type="elpub" pub-id-type="custom">actabiomedica-4219</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>СТОМАТОЛОГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>STOMATOLOGY</subject></subj-group></article-categories><title-group><article-title>Функциональная активность эндотелия полости рта у лиц, страдающих хроническим пародонтитом, при лечении методом плазмолифтинга</article-title><trans-title-group xml:lang="en"><trans-title>Functional activity of the oral endothelium in persons, with chronic periodontitis during treatment with plasmolifting</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1272-5610</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Фефелов</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Fefelov</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Фефелов Александр Александрович – врач-стоматолог-хирург</p><p>672027, г. Чита, ул. Угданская, 8, Россия</p></bio><bio xml:lang="en"><p> Alexander A. Fefelov – Dentist Surgeon </p><p>Ugdanskaya str. 8, Chita 672027, Russian Federation</p></bio><email xlink:type="simple">thedantists@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0975-2351</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Цыбиков</surname><given-names>Н. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Tsybikov</surname><given-names>N. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Цыбиков Намжил Нанзатович – доктор медицинских наук, профессор, заведующий кафедрой патологической физиологии</p><p>672000, г. Чита, ул. Горького, 39а, Россия </p></bio><bio xml:lang="en"><p>Namzhil N. Tsybikov – Dr. Sc. (Med.), Professor, Head of the Department of Pathological Physiology </p><p>Gorkogo str. 39A, Chita 672000, Russian Federation </p></bio><email xlink:type="simple">thybikov@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3588-6545</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шолохов</surname><given-names>Л. Ф.</given-names></name><name name-style="western" xml:lang="en"><surname>Sholokhov</surname><given-names>L. F.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Шолохов Леонид Федорович – доктор медицинских наук, профессор, заведующий лабораторией физиологии и патологии эндокринной системы</p><p>664003, г. Иркутск, ул. Тимирязева, 16, Россия </p></bio><bio xml:lang="en"><p>Leonid F. Sholokhov – Dr. Sc. (Med.), Professor, Head of the Laboratory of Physiology and Pathology of the Endocrine System </p><p>Timiryazeva str. 16, Irkutsk 664003, Russian Federation</p></bio><email xlink:type="simple">lfshol@mail.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0724-0352</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Фефелова</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Fefelova</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Фефелова Елена Викторовна – доктор медицинских наук, доцент кафедры патологической физиологии</p><p>672000, г. Чита, ул. Горького, 39а, Россия </p></bio><bio xml:lang="en"><p>Elena V. Fefelova – Dr. Sc. (Med.), Associate Professor of the Department of Pathological Physiology </p><p>Gorkogo str. 39A, Chita 672000, Russian Federation </p></bio><email xlink:type="simple">fefelova.elena@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ГАУЗ «Краевая стоматологическая поликлиника»</institution></aff><aff xml:lang="en"><institution>Regional Dental Clinic</institution></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБОУ ВО «Читинская государственная медицинская академия» Минздрава России</institution></aff><aff xml:lang="en"><institution>Chita State Medical Academy</institution></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГБНУ «Научный центр проблем здоровья семьи и репродукции человека»</institution></aff><aff xml:lang="en"><institution>Scientific Centre for Family Health and Human Reproduction Problems</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>11</day><month>07</month><year>2023</year></pub-date><volume>8</volume><issue>3</issue><fpage>154</fpage><lpage>160</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Фефелов А.А., Цыбиков Н.Н., Шолохов Л.Ф., Фефелова Е.В., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Фефелов А.А., Цыбиков Н.Н., Шолохов Л.Ф., Фефелова Е.В.</copyright-holder><copyright-holder xml:lang="en">Fefelov A.A., Tsybikov N.N., Sholokhov L.F., Fefelova E.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.actabiomedica.ru/jour/article/view/4219">https://www.actabiomedica.ru/jour/article/view/4219</self-uri><abstract><p>Хронический пародонтит как остеоиммунное заболевание полости рта сопровождается изменением функциональной активности эндотелиоцитов. Причём аномальная васкуляризация усугубляет воспаление пародонта, так как способствует трансмиграции большего количества иммунокомпетентных клеток, притоку медиаторов воспаления и цитокинов.</p><p>Целью нашей работы явилось изучение функциональной активности эндотелия сосудов полости рта у лиц, страдающих хроническим пародонтитом, при лечении методом плазмолифтинга.</p><sec><title>Материалы и методы</title><p>Материалы и методы. Под наблюдением находилось 30 пациентов с диагностированным хроническим генерализованным пародонтитом средней степени тяжести (15 мужчин и 15 женщин) в возрасте 35 (32,50; 40,00) лет, с отсутствующей тяжёлой соматической патологией (основная группа). В группу сравнения были включены 20 человек, сопоставимые с основной группой по полу и возрасту, с отсутствием воспалительных заболеваний в полости рта. Всем больным проводилась местная противовоспалительная терапия и санация пародонтальных карманов, коррекция окклюзионных контактов, кюретаж, плазмолифтинг. В ротовой жидкости определяли концентрацию растворимых молекул адгезии ICAM-1 и VCAM-1, эндотелин-1, качественный и количественный состав микрофлоры.</p></sec><sec><title>Результаты</title><p>Результаты. После проведённого лечения плазмолифтингом наблюдалось заметное купирование активности воспалительного процесса. У пациентов с хроническим пародонтитом в 100 % случаев обнаружена Porphyromonas gingivalis в титре 5,73 (4,9; 6,7) lg (ГЭ/образец), у 62,5 % – Prevotella intermedia в титре 4,5 (3,0; 5,5) lg (ГЭ/образец). На фоне терапии наблюдалось снижение как встречаемости микроорганизма, так и количества микроорганизмов. Концентрация растворимой формы VCAM-1 в ротовой жидкости больных хроническим пародонтитом превышала уровень контрольной группы в 38,3 раза (р = 0,000001), а ICAM-1 – в 18,1 раза (р = 0,00001). На фоне терапии плазмолифтингом концентрация изучаемых веществ снижалась, но превышала значения контроля в 25,2 и 6,4 раза соответственно. Содержание эндотелина в ротовой жидкости у больных пародонтитом увеличивалось на 40,7 % (р = 0,003), а на фоне терапии снижалось, но не достигало уровня здоровых добровольцев (р = 0,04).</p></sec></abstract><trans-abstract xml:lang="en"><p>Chronic periodontitis as an osteoimmune disease of the oral cavity is accompanied by a change in the functional activity of endotheliocytes. Moreover, abnormal vascularization exacerbates periodontal inflammation, as it promotes the transmigration of a larger number of immunocompetent cells, the influx of inflammatory mediators and cytokines.</p><p>The aim of our work was to study the functional activity of the endothelium of the vessels of the oral cavity in persons suffering from chronic periodontitis in the treatment of plasmolifting.</p><sec><title>Materials and methods</title><p>Materials and methods. Under observation were 30 patients diagnosed with chronic generalized periodontitis of moderate severity at the age of 35 (32.50; 40.00) years, with no severe somatic pathology (main group). The comparison group included 20 people aged 38 (34.00; 45.00) years with no inflammatory diseases in the oral cavity. All patients underwent local anti-inflammatory therapy and sanitation of periodontal pockets, correction of occlusal contacts, curettage, plasma lifting. Oral fluid concentration of soluble adhesion molecules ICAM-1 and VCAM-1, endothelin-1, qualitative and quantitative composition of microflora were determined.</p></sec><sec><title>Results</title><p>Results. After the treatment with plasmolifting, a noticeable relief of the activity of the inflammatory process was observed. In patients with chronic periodontitis, Porphyromonas gingivalis was found in 100 % of cases in a titer of 5.73 (4.9; 6.7) lg (gEq/sample), in 62.5 % – Prevotella intermedia in a titer of 4.5 (3.0; 5.5) lg (gEq/sample). Against the background of therapy, decrease of the occurrence of the microorganism and of the number of microorganisms was observed. The concentration of the soluble form of VCAM-1 in the oral fluid of patients with chronic periodontitis exceeded the values of the control group by 38.3 times (p = 0.000001), and ICAM-1 – by 18.1 times (p = 0.00001). Against the background of plasmolifting therapy, the level of the studied substances decreased, but exceeded the control values by 25.2 and 6.4 times, respectively. The content of endothelin in the oral fluid in patients with periodontitis exceeded the values of healthy individuals by 40.7 % (p = 0.003), during therapy its values decreased, but did not reach the level of healthy volunteers (p = 0.04).</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>дисфункция эндотелия</kwd><kwd>хронический пародонтит</kwd><kwd>плазмолифтинг</kwd><kwd>молекулы клеточной адгезии</kwd><kwd>эндотелин-1</kwd></kwd-group><kwd-group xml:lang="en"><kwd>endothelial dysfunction</kwd><kwd>chronic periodontitis</kwd><kwd>plasmolifting</kwd><kwd>cell adhesion molecules</kwd><kwd>endothelin-1</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Kinane DF, Stathopoulou PG, Papapanou PN. Periodontal diseases. Nat Rev Dis Primers. 2017; 3: 17038. doi: 10.1038/nrdp.2017.38</mixed-citation><mixed-citation xml:lang="en">Kinane DF, Stathopoulou PG, Papapanou PN. Periodontal diseases. Nat Rev Dis Primers. 2017; 3: 17038. doi: 10.1038/nrdp.2017.38</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Martín-Fernández M, Tamayo-Velasco Á, Aller R, Gonzalo-Benito H, Martínez-Paz P, Tamayo E. Endothelial dysfunction and neutrophil degranulation as central events in sepsis physiopathology. Int J Mol Sci. 2021; 22(12): 6272. doi: 10.3390/ijms22126272</mixed-citation><mixed-citation xml:lang="en">Martín-Fernández M, Tamayo-Velasco Á, Aller R, GonzaloBenito H, Martínez-Paz P, Tamayo E. Endothelial dysfunction and neutrophil degranulation as central events in sepsis physiopathology. Int J Mol Sci. 2021; 22(12): 6272. doi: 10.3390/ijms22126272</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Ларёва Н.В., Гордеева О.О. Место молекул клеточной адгезии в патогенезе хронической обструктивной болезни легких и артериальной гипертензии в гендерном аспекте. Забайкальский медицинский вестник. 2018; 1: 87-97. doi: 10.52485/19986173_2018_1_87</mixed-citation><mixed-citation xml:lang="en">Lareva NV, Gordeeva OO. Place of cell adhesion molecules in the pathogenesis of chronic obstructive pulmonary disease and arterial hypertension in the gender aspect. The Transbailalian Medical Bulletin. 2018; 1: 87-97. (In Russ.). doi: 10.52485/19986173_2018_1_87</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Дорофиенко Н.Н. Роль сосудистого эндотелия в организме и универсальные механизмы изменения его активности (обзор литературы). Бюллетень физиологии и патологии дыхания. 2018; (68): 107-116. doi: 10.12737/article_5b1a0351210298.18315210</mixed-citation><mixed-citation xml:lang="en">Dorofienko NN. The role of vascular endothelium in the organism and the universal mechanisms of changing its activity (review). Bulletin Physiology and Pathology of Respiration. 2018; (68): 107-116. (In Russ.). doi: 10.12737/article_5b1a0351210298.18315210</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Юпатов Е.Ю., Курманбаев Т.Е., Тимошкова Ю.Л. Современное понимание функции и дисфункции эндотелия сосудов. Обзор литературы. РМЖ. 2022; 30(3): 20-23.</mixed-citation><mixed-citation xml:lang="en">Yupatov EYu, Kurmanbaev TE, Timoshkova YuL. Modern understanding of the function and dysfunction of the vascular endothelium. Literature review. RMJ. 2022; 30(3): 20-23. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Van Dyke TE, Bartold PM, Reynolds EC. The nexus between periodontal inflammation and dysbiosis. Front Immunol. 2020; 11: 511. doi: 10.3389/fimmu.2020.00511</mixed-citation><mixed-citation xml:lang="en">Van Dyke TE, Bartold PM, Reynolds EC. The nexus between periodontal inflammation and dysbiosis. Front Immunol. 2020; 11: 511. doi: 10.3389/fimmu.2020.00511</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Celik D, Kantarci A. Vascular changes and hypoxia in periodontal disease as a link to systemic complications. Pathogens. 2021; 10(10): 1280. doi: 10.3390/pathogens10101280</mixed-citation><mixed-citation xml:lang="en">Celik D, Kantarci A. Vascular changes and hypoxia in periodontal disease as a link to systemic complications. Pathogens. 2021; 10(10): 1280. doi: 10.3390/pathogens10101280</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Slomiany BL, Slomiany A. Proinflammatory signaling cascades of periodontopathic oral pathogen Porphyromonas gingivalis. Journal of Biosciences and Medicines. 2018; 6(5): 63-88. doi: 10.4236/jbm.2018.65009</mixed-citation><mixed-citation xml:lang="en">Slomiany BL, Slomiany A. Proinflammatory signaling cascades of periodontopathic oral pathogen Porphyromonas gingivalis. Journal of Biosciences and Medicines. 2018; 6(5): 63-88. doi: 10.4236/jbm.2018.65009</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Whitman DH, Berry RL, Green DM. Platelet gel: An autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J Oral Maxillofac Surg. 1997; 55(11): 1294-1299. doi: 10.1016/s0278-2391(97)90187-7</mixed-citation><mixed-citation xml:lang="en">Whitman DH, Berry RL, Green DM. Platelet gel: An autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J Oral Maxillofac Surg. 1997; 55(11): 1294-1299. doi: 10.1016/s0278-2391(97)90187-7</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Xu J, Gou L, Zhang P, Li H, Qiu S. Platelet-rich plasma and regenerative dentistry. Aust Dent J. 2020; 65(2): 131-142. doi: 10.1111/adj.12754</mixed-citation><mixed-citation xml:lang="en">Xu J, Gou L, Zhang P, Li H, Qiu S. Platelet-rich plasma and regenerative dentistry. Aust Dent J. 2020; 65(2): 131-142. doi: 10.1111/adj.12754</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Официальный сайт Стоматологической ассоциации России. URL: https://www.e-stomatology.ru/director/protokols/ [date of access: 01.09.2023].</mixed-citation><mixed-citation xml:lang="en">Official website of the Dental Association of Russia. (In Russ.) URL: https://www.e-stomatology.ru/director/protokols/ [date of access: 01.09.2023].</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Sharma R, Khaket TP, Dutta C, Chakraborty B, Mukherjee TK. Breast cancer metastasis: Putative therapeutic role of vascular cell adhesion molecule-1. Cell Oncol (Dordr). 2017, 40(3): 199-208. doi: 10.1007/s13402-017-0324-x</mixed-citation><mixed-citation xml:lang="en">Sharma R, Khaket TP, Dutta C, Chakraborty B, Mukherjee TK. Breast cancer metastasis: Putative therapeutic role of vascular cell adhesion molecule-1. Cell Oncol (Dordr). 2017, 40(3): 199-208. doi: 10.1007/s13402-017-0324-x</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Cerutti C, Ridley AJ. Endothelial cell-cell adhesion and signaling. Exp Cell Res. 2017, 358(1): 31-38. doi: 10.1016/j.yexcr.2017.06.003</mixed-citation><mixed-citation xml:lang="en">Cerutti C, Ridley AJ. Endothelial cell-cell adhesion and signaling. Exp Cell Res. 2017, 358(1): 31-38. doi: 10.1016/j.yexcr.2017.06.003</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Woska JR, Morelock MM, Durham Jeanfavre D, Caviness GO, Bormann BJ, Rothlein R. Molecular comparison of soluble intercellular adhesion molecule (sICAM-1) and sICAM-3 binding to lymphocyte function-associated antigen-1. J Biol Chem. 1998; 273(8): 4725-4733. doi: 10.1074/jbc.273.8.4725</mixed-citation><mixed-citation xml:lang="en">Woska JR, Morelock MM, Durham Jeanfavre D, Caviness GO, Bormann BJ, Rothlein R. Molecular comparison of soluble intercellular adhesion molecule (sICAM-1) and sICAM-3 binding to lymphocyte function-associated antigen-1. J Biol Chem. 1998; 273(8): 4725-4733. doi: 10.1074/jbc.273.8.4725</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Champagne B, Tremlay P, Cantin A, St. Pierre I. Proteolytic cleavage of ICAM-1 by human neutrophil elastase. J Immunol. 1998; 161(11): 6398-6405.</mixed-citation><mixed-citation xml:lang="en">Champagne B, Tremlay P, Cantin A, St. Pierre I. Proteolytic cleavage of ICAM-1 by human neutrophil elastase. J Immunol. 1998; 161(11): 6398-6405.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Müller N. The role of intercellular adhesion molecule-1 in the pathogenesis of psychiatric disorders. Front Pharmacol. 2019; 10: 1251. doi: 10.3389/fphar.2019.01251</mixed-citation><mixed-citation xml:lang="en">Müller N. The role of intercellular adhesion molecule-1 in the pathogenesis of psychiatric disorders. Front Pharmacol. 2019; 10: 1251. doi: 10.3389/fphar.2019.01251</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Кибалина И.В., Цыбиков Н.Н. Роль эндотелина-1 и аутоантител к нему в патогенезе атопического дерматита: исследование случай-контроль. Вестник дерматологии и венерологии. 2021; 97(1): 34-40. doi: 10.25208/vdv478</mixed-citation><mixed-citation xml:lang="en">Kibalina IV, Tsybikov NN. The role of endothelin-1 and its autoantibodies in the pathogenesis of atopic dermatitis: A case-control study. Vestnik dermatologii i venerologii. 2021; 97(1): 34-40. (In Russ.). doi: 10.25208/vdv478</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Fagan KA, McMurtry IF, Rodman DM. Role of endothelin-1 in lung disease. Respir Res. 2001; 2(2): 90-101. doi: 10.1186/rr44</mixed-citation><mixed-citation xml:lang="en">Fagan KA, McMurtry IF, Rodman DM. Role of endothelin-1 in lung disease. Respir Res. 2001; 2(2): 90-101. doi: 10.1186/rr44</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Nagao RJ, Marcu R, Wang Y, Wang L, Arakawa C, DeForest C, et al. Transforming endothelium with platelet-rich plasma in engineered microvessels. Adv Sci (Weinh). 2019; 6(24): 1901725. doi: 10.1002/advs.201901725</mixed-citation><mixed-citation xml:lang="en">Nagao RJ, Marcu R, Wang Y, Wang L, Arakawa C, DeForest C, et al. Transforming endothelium with platelet-rich plasma in engineered microvessels. Adv Sci (Weinh). 2019; 6(24): 1901725. doi: 10.1002/advs.201901725</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
